Intuitive Surgical Return on Tangible Equity 2012-2025 | ISRG
Current and historical return on tangible equity values for Intuitive Surgical (ISRG) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Intuitive Surgical Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $2.75B | $15.87B | 17.12% |
| 2025-06-30 | $2.61B | $16.80B | 16.57% |
| 2025-03-31 | $2.48B | $16.07B | 16.53% |
| 2024-12-31 | $2.32B | $15.41B | 16.32% |
| 2024-09-30 | $2.24B | $14.66B | 16.63% |
| 2024-06-30 | $2.09B | $13.79B | 16.45% |
| 2024-03-31 | $1.99B | $13.09B | 16.55% |
| 2023-12-31 | $1.80B | $12.41B | 15.91% |
| 2023-09-30 | $1.52B | $11.64B | 14.16% |
| 2023-06-30 | $1.43B | $10.92B | 13.66% |
| 2023-03-31 | $1.31B | $10.23B | 12.55% |
| 2022-12-31 | $1.32B | $10.05B | 12.38% |
| 2022-09-30 | $1.38B | $10.52B | 12.63% |
| 2022-06-30 | $1.44B | $11.03B | 13.15% |
| 2022-03-31 | $1.65B | $11.15B | 15.45% |
| 2021-12-31 | $1.71B | $10.98B | 16.73% |
| 2021-09-30 | $1.69B | $10.53B | 17.45% |
| 2021-06-30 | $1.62B | $9.94B | 17.70% |
| 2021-03-31 | $1.17B | $9.32B | 13.53% |
| 2020-12-31 | $1.06B | $8.92B | 12.83% |
| 2020-09-30 | $1.05B | $8.48B | 13.30% |
| 2020-06-30 | $1.14B | $7.96B | 15.03% |
| 2020-03-31 | $1.39B | $7.71B | 19.16% |
| 2019-12-31 | $1.38B | $7.54B | 19.96% |
| 2019-09-30 | $1.32B | $7.06B | 19.99% |
| 2019-06-30 | $1.21B | $6.65B | 19.32% |
| 2019-03-31 | $1.15B | $6.41B | 19.25% |
| 2018-12-31 | $1.13B | $6.19B | 20.04% |
| 2018-09-30 | $0.80B | $5.82B | 15.51% |
| 2018-06-30 | $0.81B | $5.44B | 16.59% |
| 2018-03-31 | $0.78B | $5.10B | 17.04% |
| 2017-12-31 | $0.67B | $4.38B | 15.84% |
| 2017-09-30 | $0.91B | $4.60B | 20.05% |
| 2017-06-30 | $0.82B | $4.17B | 17.53% |
| 2017-03-31 | $0.78B | $3.79B | 16.14% |
| 2016-12-31 | $0.74B | $5.58B | 14.73% |
| 2016-09-30 | $0.72B | $5.21B | 15.65% |
| 2016-06-30 | $0.68B | $4.84B | 15.92% |
| 2016-03-31 | $0.63B | $4.42B | 16.04% |
| 2015-12-31 | $0.59B | $4.00B | 16.23% |
| 2015-09-30 | $0.55B | $3.78B | 16.09% |
| 2015-06-30 | $0.50B | $3.47B | 16.04% |
| 2015-03-31 | $0.47B | $3.27B | 16.33% |
| 2014-12-31 | $0.42B | $3.06B | 14.34% |
| 2014-09-30 | $0.44B | $2.75B | 14.72% |
| 2014-06-30 | $0.47B | $2.49B | 15.46% |
| 2014-03-31 | $0.53B | $3.40B | 15.95% |
| 2013-12-31 | $0.67B | $3.27B | 20.14% |
| 2013-09-30 | $0.68B | $3.04B | 20.30% |
| 2013-06-30 | $0.71B | $3.49B | 21.00% |
| 2013-03-31 | $0.70B | $3.53B | 21.72% |
| 2012-12-31 | $0.66B | $3.34B | 21.72% |
| 2012-09-30 | $0.63B | $3.09B | 22.56% |
| 2012-06-30 | $0.57B | $2.97B | 22.19% |
| 2012-03-31 | $0.53B | $2.71B | 22.61% |
| 2011-12-31 | $0.49B | $2.46B | 22.50% |
| 2011-09-30 | $0.46B | $2.18B | 22.70% |
| 2011-06-30 | $0.43B | $2.10B | 21.94% |
| 2011-03-31 | $0.40B | $2.04B | 21.44% |
| 2010-12-31 | $0.38B | $1.85B | 21.69% |
| 2010-09-30 | $0.34B | $1.82B | 20.66% |
| 2010-06-30 | $0.32B | $1.76B | 21.28% |
| 2010-03-31 | $0.29B | $1.61B | 21.92% |
| 2009-12-31 | $0.23B | $1.37B | 19.91% |
| 2009-09-30 | $0.21B | $1.22B | 18.68% |
| 2009-06-30 | $0.20B | $1.10B | 18.92% |
| 2009-03-31 | $0.19B | $1.00B | 18.64% |
| 2008-12-31 | $0.21B | $1.10B | 21.09% |
| 2008-09-30 | $0.20B | $1.02B | 22.92% |
| 2008-06-30 | $0.19B | $0.92B | 23.18% |
| 2008-03-31 | $0.17B | $0.85B | 23.10% |
| 2007-12-31 | $0.15B | $0.75B | 22.79% |
| 2007-09-30 | $0.12B | $0.68B | 21.27% |
| 2007-06-30 | $0.10B | $0.59B | 19.31% |
| 2007-03-31 | $0.08B | $0.52B | 18.50% |
| 2006-12-31 | $0.07B | $0.47B | 18.10% |
| 2006-09-30 | $0.10B | $0.42B | 27.26% |
| 2006-06-30 | $0.10B | $0.37B | 32.46% |
| 2006-03-31 | $0.10B | $0.34B | 36.87% |
| 2005-12-31 | $0.10B | $0.31B | 40.95% |
| 2005-09-30 | $0.06B | $0.23B | 29.23% |
| 2005-06-30 | $0.04B | $0.20B | 24.14% |
| 2005-03-31 | $0.03B | $0.18B | 20.19% |
| 2004-12-31 | $0.02B | $0.17B | 16.38% |
| 2004-09-30 | $0.01B | $0.15B | 5.10% |
| 2004-06-30 | $0.00B | $0.14B | -1.77% |
| 2004-03-31 | $-0.01B | $0.13B | -6.59% |
| 2003-12-31 | $-0.01B | $0.13B | -12.41% |
| 2003-09-30 | $-0.01B | $0.05B | -12.56% |
| 2003-06-30 | $-0.01B | $0.05B | -17.09% |
| 2003-03-31 | $-0.02B | $0.06B | -23.90% |
| 2002-12-31 | $-0.02B | $0.06B | -29.01% |
| 2002-09-30 | $-0.02B | $0.06B | -28.99% |
| 2002-06-30 | $-0.02B | $0.07B | -26.03% |
| 2002-03-31 | $-0.02B | $0.07B | -24.84% |
| 2001-12-31 | $-0.02B | $0.08B | -19.94% |
| 2001-09-30 | $-0.02B | $0.08B | -20.42% |
| 2001-06-30 | $-0.02B | $0.08B | -18.39% |
| 2001-03-31 | $-0.02B | $0.09B | -17.93% |
| 2000-12-31 | $-0.02B | $0.09B | -22.22% |
| 2000-06-30 | $-0.01B | $0.09B | -29.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $196.001B | $8.352B |
| Intuitive Surgical Inc designs, manufactures and markets the da Vinci surgical system and related instruments and accessories, which is an advanced robot-assisted surgical system. The surgical system comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging. Intuitive Surgical's robot-based da Vinci surgical system enables minimally-invasive surgery that reduces the trauma associated with open surgery. The company also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures.?Additionally, the company sells various accessories comprising sterile drapes and vision products and other items that facilitate use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. The company operates through three segments: Instruments and Accessories, Systems and Services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.627B | 27.76 |
| IDEXX Laboratories (IDXX) | United States | $56.733B | 56.34 |
| Edwards Lifesciences (EW) | United States | $48.223B | 32.33 |
| IQVIA Holdings (IQV) | United States | $41.102B | 22.92 |
| Alcon (ALC) | Switzerland | $39.514B | 26.70 |
| Mettler-Toledo (MTD) | United States | $30.348B | 35.51 |
| DexCom (DXCM) | United States | $27.184B | 37.47 |
| STERIS (STE) | Ireland | $25.935B | 26.77 |
| Waters (WAT) | United States | $23.414B | 30.96 |
| Coloplast (CLPBY) | Denmark | $20.103B | 34.31 |
| Hologic (HOLX) | United States | $16.754B | 17.60 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.523B | 0.00 |
| Globus Medical (GMED) | United States | $12.375B | 25.97 |
| Penumbra (PEN) | United States | $12.275B | 86.34 |
| Masimo (MASI) | United States | $7.435B | 23.82 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.998B | 0.00 |
| TransMedics (TMDX) | United States | $4.851B | 57.47 |
| Teleflex (TFX) | United States | $4.554B | 7.26 |
| Veracyte (VCYT) | United States | $3.356B | 38.24 |
| LivaNova (LIVN) | United Kingdom | $3.323B | 17.95 |
| Integer Holdings (ITGR) | United States | $2.968B | 13.93 |
| Elekta AB (EKTAY) | Sweden | $2.412B | 22.57 |
| Alphatec Holdings (ATEC) | United States | $2.369B | 0.00 |
| Artivion (AORT) | United States | $2.013B | 92.39 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| Nihon Kohden (NHNKY) | Japan | $1.974B | 17.23 |
| PROCEPT BioRobotics (PRCT) | United States | $1.753B | 0.00 |
| AxoGen (AXGN) | United States | $1.421B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.415B | 0.00 |
| IRadimed (IRMD) | United States | $1.292B | 61.53 |
| OPKO Health (OPK) | United States | $0.998B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.976B | 5.29 |
| Pulse Biosciences (PLSE) | United States | $0.969B | 0.00 |
| SiBone (SIBN) | United States | $0.757B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.748B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.713B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.670B | 38.96 |
| Alpha Tau Medical (DRTS) | Israel | $0.636B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.567B | 0.00 |
| NeuroPace (NPCE) | United States | $0.558B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 10.99 |
| Mesa Laboratories (MLAB) | United States | $0.479B | 13.22 |
| OrthoPediatrics (KIDS) | United States | $0.462B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.438B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.422B | 0.00 |
| RxSight (RXST) | United States | $0.398B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 61.06 |
| Sight Sciences (SGHT) | United States | $0.364B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.327B | 2.44 |
| Spectral Diagnostics (EDTXF) | Canada | $0.310B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.197B | 0.00 |
| 908 Devices (MASS) | United States | $0.197B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.186B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.171B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
| CVRx (CVRX) | United States | $0.159B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.151B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.145B | 0.00 |
| Solana (HSDT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| Neuronetics (STIM) | United States | $0.121B | 0.00 |
| Hyperfine (HYPR) | United States | $0.120B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.078B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.050B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.28 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |